Detalhe da pesquisa
1.
Acceptable, hopeful, and useful: development and mixed-method evaluation of an educational tool about reproductive options for people with sickle cell disease or trait.
J Assist Reprod Genet
; 39(1): 183-193, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34806131
2.
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with multiple myeloma.
BMC Cancer
; 21(1): 1354, 2021 Dec 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34961488
3.
Temporary hold of mycophenolate augments humoral response to SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases: a case series.
Ann Rheum Dis
; 81(2): 293-295, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34556484
4.
Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series.
Ann Intern Med
; 174(9): 1332-1334, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34029488
5.
High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 80(10): 1351-1352, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031032
6.
Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 80(8): 1098-1099, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33757968
7.
Safety ofâ¯theâ¯firstâ¯dose ofâ¯mRNA SARS-CoV-2â¯vaccines inâ¯patients with rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 80(8): 1100-1101, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33741555
8.
Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.
Ann Rheum Dis
; 80(10): 1365-1366, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34429320
9.
Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination.
Arthritis Rheumatol
; 74(1): 28-32, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34346185
10.
Safety and antibody response to the first dose of severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine in persons with HIV.
AIDS
; 35(11): 1872-1874, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33993131
11.
Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV.
AIDS
; 35(14): 2399-2401, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34261097
12.
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
Transplantation
; 105(10): 2170-2174, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859151